Orphan Drugs Market Regional Analysis Forecast till 2025

1
Orphan Drugs Market Size, Share and Global Trend
By Therapy Area (Oncology, Blood, CNS, Endocrine,
Cardiovascular, Respiratory, Immunomodulatory),
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Sales) and Geography Forecast
till 2025
Buy Now
Sample PDF
Get Discount
Published Date April 2019 Report Format PDF
Region Global Base Year 2018
2
Orphan Drugs Market Size, Share and Global Trend
By Therapy Area (Oncology, Blood, CNS, Endocrine,
Cardiovascular, Respiratory, Immunomodulatory),
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Sales) and Geography Forecast
till 2025
Report Highlights As per Fortune Business
Insights, the North America Orphan Drugs Market
was worth US 67,136.0 Mn in 2017 and will
continue to rise at a steady pace until 2025.
This is mainly ascribable to the rising awareness
among people regarding the use of novel drugs. In
addition to this, North America is expected to
offer attractive growth opportunities on the back
of recent FDA approvals on the development of
orphan drugs. Governments in North America are
increasingly spending on research and development
(RD) of orphan drugs and technologies. North
America is expected to remain dominant in the
Global Orphan Drugs Market between 2018 and
2025. This information was found by Fortune
Business Insights in a report, titled Orphan
Drugs Market Global Market Analysis, Insights
and Forecast, 2018-2025.
3
Orphan Drugs Market Size, Share and Global Trend
By Therapy Area (Oncology, Blood, CNS, Endocrine,
Cardiovascular, Respiratory, Immunomodulatory),
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Sales) and Geography Forecast
till 2025
Rising Prevalence of Cancer and Related Diseases
Fuels Demand Orphan Drugs The oncology segment
is witnessing considerably high demand on account
of the rising number of patients suffering from
different types of cancers. This also increases
the demand for novel therapeutics, which as per
the report will bode well for the global orphan
drugs market. According to the National Center
for Health Statistics, the U.S. is likely to
witness around 1,762,450 new cancer cases in
2019. Treatment and Medications Associated with
Rare Diseases Are Expensive, Limiting Growth of
Orphan Drugs Market Although the orphan drugs
market is growing at a good pace, there are some
factors that may hinder its growth. The high cost
of orphan drugs, insufficient information on rare
diseases, and lack of skilled healthcare
professionals are factors restricting growth in
the global orphan drugs market. In addition to
this, rising competition from generic industries
may pose a serious threat to the growth of the
market. Browse Complete Report
Details https//www.fortunebusinessinsights.com/i
ndustry-reports/orphan-drugs-market-100088
4
Orphan Drugs Market Size, Share and Global Trend
By Therapy Area (Oncology, Blood, CNS, Endocrine,
Cardiovascular, Respiratory, Immunomodulatory),
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Sales) and Geography Forecast
till 2025
People across the world are becoming more aware
of the rising prevalence of rare disorders and
importance of orphan drugs, stated a lead
analyst at Fortune Business Insights. This,
coupled with robust support from the EU and FDA
to drug development, drives the orphan drugs
market, he added. Several pharma companies are
also putting continuous efforts to develop orphan
drugs, thus improving creating scope for
generating more revenue in the overall global
market for orphan drugs. Top Players
Mentioned This is mainly because of rapid drug
development and discovery over the years. Several
leading companies are manufacturing orphan drugs
to build a nimble and agile framework. Some of
the savvy players present in the global orphan
drugs market are Actelion Pharmaceuticals Ltd.,
Biogen, Eli Lilly and Company, Bayer AG, Amgen
Inc., and Pfizer Inc. These leading players are
likely to give tough competition to the small
entrants. Therefore, these small scale companies
may need support from governments and other
authorities to sustain in the market. Get
Customization https//www.fortunebusinessinsights
.com/enquiry/customization/orphan-drugs-market-100
088
5
Orphan Drugs Market Size, Share and Global Trend
By Therapy Area (Oncology, Blood, CNS, Endocrine,
Cardiovascular, Respiratory, Immunomodulatory),
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Sales) and Geography Forecast
till 2025
About Us Fortune Business Insights offers expert
corporate analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them to address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence, giving
a granular overview of the market they are
operating in.    Our reports contain a unique mix
of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our
team of experienced analysts and consultants use
industry-leading research tools and techniques to
compile comprehensive market studies,
interspersed with relevant data.    Phone US 1
424 253 0390 UK 44 2071 939123 APAC 91 744
740 1245 Email sales_at_fortunebusinessinsights.com